HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of neutral endopeptidase in exercise-induced bronchoconstriction in asthmatic subjects.

Abstract
The membrane-bound metalloproteinase, neutral endopeptidase (NEP), is a degrading enzyme of both bronchoconstrictor and bronchodilator peptides within the airways. To examine the role of NEP in exercise-induced bronchoconstriction (EIB) in asthmatic subjects, we used inhaled thiorphan, a NEP inhibitor, as pretreatment to a 6-min standardized exercise challenge. Thirteen clinically stable asthmatic subjects participated in this double-blind, placebo-controlled, crossover study that was performed on 2 days separated by 48 h. Thiorphan was administered by two inhalations of 0.5 ml containing 1.25 mg/ml. Subsequently, exercise was performed on a bicycle ergometer at 40-50% of predicted maximal voluntary ventilation while inhaling dry air (20 degrees C, relative humidity 6%). The airway response to exercise was measured by forced expiratory volume in 1 s (FEV1) every 3 min, up to 30 min postexercise challenge, and was expressed both as the maximal percent fall in FEV1 from baseline and as the area under the time-response curve (AUC) (0-30 min). The acute effects of both pretreatments on baseline FEV1 were not different (P > 0.2), neither was there any difference in maximal percent fall in FEV1 between thiorphan and placebo (P > 0.7). However, compared with placebo, thiorphan reduced the AUC by, on average, 26% [AUC (0-30 min, +/-SE): 213.6 +/- 47.7 (thiorphan) and 288.6 +/- 46.0%fall.h (placebo); P = 0.047]. These data indicate that NEP inhibition by thiorphan reduces EIB during the recovery period. This suggests that bronchodilator NEP substrates, such as vasoactive intestinal polypeptide or atrial natriuretic peptide, modulate EIB in patients with asthma.
AuthorsH W de Gouw, Z Diamant, E A Kuijpers, J K Sont, P J Sterk
JournalJournal of applied physiology (Bethesda, Md. : 1985) (J Appl Physiol (1985)) Vol. 81 Issue 2 Pg. 673-8 (Aug 1996) ISSN: 8750-7587 [Print] United States
PMID8872633 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Bronchoconstrictor Agents
  • Protease Inhibitors
  • Methacholine Chloride
  • Thiorphan
  • Neprilysin
Topics
  • Administration, Inhalation
  • Adolescent
  • Adult
  • Area Under Curve
  • Asthma, Exercise-Induced (enzymology, physiopathology)
  • Bronchial Diseases (enzymology, physiopathology)
  • Bronchoconstrictor Agents (pharmacology)
  • Constriction, Pathologic (enzymology, physiopathology)
  • Double-Blind Method
  • Exercise Test
  • Female
  • Forced Expiratory Volume
  • Humans
  • Male
  • Methacholine Chloride (pharmacology)
  • Neprilysin (antagonists & inhibitors, physiology)
  • Protease Inhibitors (administration & dosage, pharmacology)
  • Thiorphan (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: